Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • metheuse
    Member
    • Jan 2013
    • 84

    #1

    Hybrid assembling using PacBioToCA?

    This may be a silly question. I know PacBioToCA can be used to correct PacBio long reads by alignment from, for example, Illumina short reads. Then the corrected PacBio reads can be assembled, for example, by Celera assembler. Is this "hybrid" assembly?
    In this pipeline, illumina reads are only used for error correction, but not used in assembling? Should both PacBio reads and illumina reads be used in Celera for assembling as "hybrid" assembly?
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    Hybrid in sense that assembly is driven by two technologies.

    There are all sorts of variants of hybrids -- cleaning reads (as you've described), co-assembly, merging independent assemblies made with different technologies & assembling with one technology & correcting the consensus with another -- and mix-and-match of all of those

    Comment

    • metheuse
      Member
      • Jan 2013
      • 84

      #3
      Originally posted by krobison View Post
      Hybrid in sense that assembly is driven by two technologies.

      There are all sorts of variants of hybrids -- cleaning reads (as you've described), co-assembly, merging independent assemblies made with different technologies & assembling with one technology & correcting the consensus with another -- and mix-and-match of all of those
      Thanks. So my follow-up question is: is the pacbiotoca--> celera workflow a good way of "hybrid" assembly? Does it fully use the information from two technologies? As far as I know, this is the only built-in "hybrid assembly" method in PacBio's smrtanalysis pipeline. Is it generally good?

      Comment

      • rhall
        Senior Member
        • Aug 2012
        • 324

        #4
        PacBioToCA can work well for small assemblies, computation quickly becomes an issue with larger assemblies. Smrtanalysis also includes AHA (A Hybrid Assembler) for scaffolding, but that is also limited by assembly size.

        Comment

        • metheuse
          Member
          • Jan 2013
          • 84

          #5
          Originally posted by rhall View Post
          PacBioToCA can work well for small assemblies, computation quickly becomes an issue with larger assemblies. Smrtanalysis also includes AHA (A Hybrid Assembler) for scaffolding, but that is also limited by assembly size.
          Thanks, Rhall! You've been always helpful to me!
          This should be a small genome. I'm not familiar with AHA. Is it something one can combine with the pacbioToCA-celera pipeline, or is it a parallel pipeline?

          Comment

          • rhall
            Senior Member
            • Aug 2012
            • 324

            #6
            AHA is a separate scaffolding pipeline, if you have an illumina / 454 assembly <20,000 contigs <160 Mbase you can use PacBio long reads and AHA to scaffold and close gaps in the assembly.
            You could also assembly with PacBioToCA then try scaffolding the resulting assembly with AHA in order to recover any of the sequence that was not in the PacBioToCA assembly due to illumina coverage bias.
            Results from AHA should always be validated by resequencing of raw reads, to check for missassemblies.

            Comment

            • krobison
              Senior Member
              • Nov 2007
              • 734

              #7
              Another hybrid assembler worth noting is Cerulean

              Download Cerulean: Hybrid Genome Assembler for free. Cerulean Hybrid Genome Assembler v0.1 Cerulean extends contigs assembled using short read datasets like Illumina paired-end reads using long reads like PacBio RS long reads. Cerulean v0.1 has been implemented with bacterial genomes in mind.


              and PBJelly is another PacBio scaffolder

              Comment

              • rhall
                Senior Member
                • Aug 2012
                • 324

                #8
                +1 for Cerulean, I have seen some really good results for small assemblies and it is computationally efficient.
                Another option for a small genomes, even if you don't have enough coverage to get great denovo PacBio results, HGAP you will still give reasonable sized assemblies with 35-40x coverage, just very fragmented. You could assemble everything independently and merge the assemblies with something like minimus2.

                Comment

                • metheuse
                  Member
                  • Jan 2013
                  • 84

                  #9
                  Thank you guys so much. I'll take a look into Cerulean.

                  Comment

                  • akorobeynikov
                    Member
                    • Sep 2013
                    • 25

                    #10
                    SPAdes 3.0 (http://bioinf.spbau.ru/en/spades) includes support for hybrid assemblies from Illumina/IonTorrent+PacBio. Additional information (like old contigs, Sanger reads) can be added as well.

                    Comment

                    Latest Articles

                    Collapse

                    • SEQadmin2
                      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                      by SEQadmin2



                      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                      Despite this, “CRISPR helped turn genome editing from a specialized technique into
                      ...
                      07-31-2026, 11:01 AM
                    • SEQadmin2
                      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                      by SEQadmin2


                      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                      The systematic characterization of the human proteome has
                      ...
                      07-20-2026, 11:48 AM

                    ad_right_rmr

                    Collapse

                    News

                    Collapse

                    Topics Statistics Last Post
                    Started by SEQadmin2, 08-06-2026, 07:41 AM
                    0 responses
                    14 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 08-03-2026, 10:13 AM
                    0 responses
                    31 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-31-2026, 02:55 AM
                    0 responses
                    41 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-24-2026, 12:17 PM
                    0 responses
                    26 views
                    0 reactions
                    Last Post SEQadmin2  
                    Working...